home / stock / anip / anip articles

ANIP Articles, ANI Pharmaceuticals Inc.

Stock Information
Company Name: ANI Pharmaceuticals Inc.
Stock Symbol: ANIP
Market: NASDAQ
Website: anipharmaceuticals.com
Menu
ANIP ANIP Quote ANIP Short ANIP News ANIP Articles ANIP Message Board
Get ANIP Alerts

News, Short Squeeze, Breakout and More Instantly...
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
ANI Pharmaceuticals' CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner | Benzinga

PRINCETON, N.J., June 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that its Chief ...

Nasdaq Records Worst Session Since April With Nvidia Plunging 7%: Dow Jones Sees Modest Gains Amid Mixed Market Close | Benzinga

The CNN Money Fear and Greed index showed some improvement in the overall market sentiment, while the index remained in the “Fear” zone...

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal | Benzinga

On Monday, ANI Pharmaceuticals Inc (NASDAQ:ANIP) agreed to acquire Alimera Sciences Inc (NASDAQ:ALIM) for $5.50 per share in cash and one non-trada...
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences | Benzinga

Conference call scheduled for today at 8:30 a.m. ET Strengthens Rare Disease segment as largest driver of future growth, expected to add approxim...

Insider Selling: Stephen P Carey Unloads $317K Of ANI Pharmaceuticals Stock | Benzinga

Stephen P Carey, SVP & CFO at ANI Pharmaceuticals (NASDAQ:ANIP), disclosed an insider sell on June 6, according to a recent SEC filing. What Ha...

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference | Benzinga

BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (NASDAQ:ANIP) today announced that Nikhil Lalwa...
Roche Cancer Drug Gets Breakthrough Therapy Designation | Benzinga

Roche (OTC: RHHBY) obtained a Breakthrough Therapy Designation for its investigational oral therapy inavolisib for treating adult breast cancer pat...

Merck Ends Keytruda Combo Melanoma Study Due to Futility | Benzinga

Merck (NYSE: MRK) announced that it is discontinuing a cohort of the phase III study evaluating a co-formulation of its blockbuster PD-L1 inhibitor...

Perrigo Q1 Earnings Surpass, Sales Miss Estimates | Benzinga

Perrigo Company plc (NYSE: PRGO) reported adjusted earnings of 29 cents per share in the first quarter of 2024, beating the Zacks Consensus Estimat...
Next 10